Lataa...
Perforation of the Colon During Imatinib Mesylate (Gleevec) Treatment in a Patient with Chronic Myeloid Leukemia (CML)
Imatinib (Gleevec; STI-571) is a tyrosine-kinase inhibitor (TKI) used in the treatment of multiple cancers, most notably Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) as well as gastrointestinal stromal tumor (GIST). The most common adverse effects with imatinib include s...
Tallennettuna:
| Julkaisussa: | Cureus |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Cureus
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4963232/ https://ncbi.nlm.nih.gov/pubmed/27489753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.660 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|